Arca
Skip to content

Metabolic syndrome

Drug research and approvals for metabolic syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 655 studies of metabolic syndrome are recruiting on ClinicalTrials.gov, and Health Canada has authorized 11 drug trials for it since 2013.

  • Recruiting worldwide: 655
  • Trials authorized in Canada: 11
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 655 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 11; search them all in Canada trials
Jan 2, 2024A single center, phase 1, randomized, double-blind, placebo-controlled single and multiple ascending dose study to evaluate the safety, tolerability, and…INV-347INVERSAGO PHARMA INCClosed
May 2, 2023A phase 2, randomized, double-blind, placebo-controlled, and open-label extension study of the efficacy, safety, and pharmacokinetics of three doses of inv-202…INV-202INVERSAGO PHARMA INCClosed
Sep 6, 202212-month randomized, multicenter, double-blind, placebo-controlled phase 3 study to evaluate the safety and efficacy of daily subcutaneous metreleptin…METRELEPTIN FOR INJECTIONChiesi Farmaceutici S.p.A.Closed
Jan 19, 2022A phase 1b study to examine the pharmacokinetic and pharmacodynamic effects of inv-202 in subjects with metabolic syndrome as defined by hypertriglyceridemia,…INV-202INVERSAGO PHARMA INCOngoing
Jul 3, 2019Effect of vitamin d on reducing body fat and improving metabolic syndrome in the newfoundland population (open label)VITAMIN D3MEMORIAL UNIVERSITYPending
Feb 16, 2018Fecal microbial transplantation and fiber supplementation in subjects with obesity and metabolic syndromeFECAL MICROBIOTA FOR TRANSPLANTATION (FMT)GOVERNORS OF THE UNIVERSITY OF ALBERTAClosed
Mar 7, 2017A randomized phase 3 trial of metformin in patients initiating androgen deprivation therapy as prevention and intervention of metabolic syndrome: the prime…METFORMINCANADIAN UROLOGICAL ONCOLOGY GROUPClosed
Nov 10, 2016A phase 2, double-blind, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of pbi-4050 in type 2 diabetes mellitus patients with…PBI-4050PROMETIC PHARMA SMT LTDClosed
Jun 6, 2016Transplantation of microbes of fecal origin for prevention and treatment of metabolic syndrome and non alchoholic fatty liver diseaseFECAL MICROBIAL TRANSPLANTST JOSEPHS HEALTHCAREOngoing
Jan 23, 2015A phase 2, single-arm, open-label study to evaluate the safety and tolerability of pbi-4050 in type 2 diabetes patients with metabolic syndromePBI-4050PROMETIC BIOSCIENCES INCClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.